Namibia:American Doctors Donate Arthroscopy Equipment
[New Era] × (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 24, 2018 Category: African Health Source Type: news
ValenTx raises $10.3 million for implantable gastric bypass device
Startup ValenTx has attracted nearly $10.3 million from 32 investors, according to a filing with the Securities & Exchange Commission.
The Maple Grove, Minn. company is developing a removable gastric bypass device as an alternative to Roux-en-Y gastric bypass surgery. It raised $10,271,050 in the round begun July 18, 2018.
The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure, according to the company’s website. This procedure does not require gastric stapling or permanent changes to the patient’s anatomy. The dev...
Source: Mass Device - August 17, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Diabetes Endoscopic / Arthroscopic Securities & Exchange Commission (SEC) valentx Source Type: news
Putting Fat Cells to Use in Orthopedics
Arthroscopic knee surgery for degenerative knee disease is a common orthopedic procedure, reportedly performed more than two million times a year globally. And these are just the statistics for knee procedures. The shoulder, hip, wrist, elbow, and ankle joints are all also candidates for arthroscopic surgeries.
A few studies have cast doubt about whether such surgeries are necessary. It is true that most of the time, patients report lessening of pain after the procedures. But could this be just a placebo effect?
In the case of osteoarthritis in the knee, there is no evidence that arthros...
Source: MDDI - August 8, 2018 Category: Medical Devices Authors: Susan Shepard Tags: Orthopedics Source Type: news
Arthroscopic subacromial decompression doesn ’t best placebo for shoulder impingement
Arthroscopic subacromial decompression (ASD) was shown to provide no benefit over diagnostic arthroscopy at 24 months in patients with shoulder impingement, according to a study published in The BMJ. (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - August 5, 2018 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news
In-office diagnostic arthroscopy may be safe and effective
In-office needle-based diagnostic imaging appears to be statistically equivalent to surgical diagnostic arthroscopy in patients with knee pain, according to an article published online in Arthroscopy. (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - August 5, 2018 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news
Acromioplasty No Better Than Sham Surgery for Shoulder Impingement Pain Acromioplasty No Better Than Sham Surgery for Shoulder Impingement Pain
Subacromial decompression is no better than diagnostic arthroscopy for treating shoulder impingement, according to the FIMACT study.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - July 31, 2018 Category: Orthopaedics Tags: Orthopaedics News Source Type: news
Lumendi wins CE Mark, launches DiLumen EIP in EU
Lumendi said today it launched its DiLumen endolumenal interventional platform endoscope sleeve after winning CE Mark approval in the European Union for the device.
The Buckinghamshire, U.K.-based company said its DiLumen EIP is a non-sterile, single-use sleeve designed to fit over standard endoscopes to stabilize the devices in the large intestine.
Lumendi touted that the device has already been used in more than 400 procedures, and has been the subject of three clinical studies, the results of which are slated to be published later this year.
“Receiving approval to apply the CE mark in Europe is critical to Lumend...
Source: Mass Device - July 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Endoscopic / Arthroscopic Regulatory/Compliance Lumendi Source Type: news
7 medtech stories we missed this week: July 13, 2018
[Image from unsplash.com]From Angiodroid receiving CE Mark approval to Masimo launching its vital signs app, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. Angiodroid wins CE Mark for Angiopulse IABP
Angiodroid announced in a July 11 press release that it has received CE Mark approval for its AngioPulse intra-aortic balloon pump device. The AngioPulse uses a new system for intra-aortic balloon pumps based on pressure regulation. It is designed for weaning solutions and is suitable for all types of patients needing intra-aortic balloon pump therapy.
2. Visura Technologies wi...
Source: Mass Device - July 13, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Diagnostics Food & Drug Administration (FDA) Imaging Patient Monitoring Regulatory/Compliance Surgical Ultrasound angiodroid Healcerio Lipogems Masimo MedTech Oculocare ReDress Visura Technologies Source Type: news
EndoGastric Solutions adds $31m
EndoGastric Solutions, which last week reported raising more than $25 million, said today that the total raise was $30.5 million.
Redmond, Wash.-based EndoGastric Solutions said the round was led by existing backers Advanced Technology Ventures, Canaan Partners, Canepa Healthcare, Chicago Growth Partners, CRG, Radius Ventures, Sightline Partners and “several new healthcare investors excited about EGS’ commercial advances.” In a regulatory filing last week the company said it raised $25.4 million from 28 investors as part of a $35.5 million offering.
Today EGS said it plans to use the infusion to back ...
Source: Mass Device - July 10, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Funding Roundup Wall Street Beat endogastricsolutions Source Type: news
FDA Clears The Way: Lipogems' Receives FDA Clearance For Microfragmented Adipose Tissue System Utilizing Body's Own Fat To Support Tissue Repair In Orthopaedic And Arthroscopic Surgeries
NORCROSS, Ga., July 5, 2018 -- (Healthcare Sales & Marketing Network) -- Lipogems, a leader in medical technologies for orthopaedic physicians, announced U.S. Food and Drug Administration (FDA) clearance of the company's Lipogems Microfragmented Adipose T... Regenerative Medicine, Orthopaedic, FDA Lipogems, Microfragmented Adipose Tissue, Transplant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 6, 2018 Category: Pharmaceuticals Source Type: news
Arthroscopy Guided Fixation of Posterior Malleolar Fractures Arthroscopy Guided Fixation of Posterior Malleolar Fractures
Find out how ankle injuries with posterior malleolar fractures were successfully treated utilizing this surgical approach.Current Orthopaedic Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 6, 2018 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news
Nerve Block Approaches for Major Arthroscopic Shoulder Surgery Nerve Block Approaches for Major Arthroscopic Shoulder Surgery
This study examined alternatives to interscalene nerve block for arthroscopic shoulder surgery, which frequently causes hemidiaphragmatic paralysis.Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2018 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news
Pulmonx wins FDA approval for Zephyr endobronchial valve
The FDA today granted pre-market approval under its breakthrough devices designation to the Zephyr endobronchial valve made by Pulmonx for treating severe emphysema.
Emphysema, a chronic obstructive pulmonary disease, causes irreversible damage to the lung’s alveoli, trapping air during exhalation that in turn can cause the diseased tissue to grow larger and pressure healthy lung tissue. The Zephyr device is designed to decrease the volume of the chest to improve function in the heart, respiratory muscles and healthy lung tissue. Inserted via bronchoscopy, the pencil-eraser-sized valves prevent air from entering th...
Source: Mass Device - June 29, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Pulmonx Source Type: news
Apollo Endosurgery wins expanded FDA nod for OverStitch Sx system
Apollo Endosurgery said today it won special FDA 510(k) clearance for its OverStitch Sx endoscopic suturing system, an accessory for its already cleared OverStitch Sx system intended to simplify attachment of the device to compatible endoscopes.
The Austin, Texas-based company said that the special clearance is the last regulatory nod it needed before it could introduce the system into the US market.
The newly cleared accessory makes the system, which was previously limited in compatibility to a select number of dual-channel endoscopes, compatible with a wider range of endoscopes, Apollo said in a press release.
Earlier t...
Source: Mass Device - June 29, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Surgical Apollo Endosurgery Source Type: news
